Avalyn Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Avalyn Pharmaceuticals's estimated annual revenue is currently $8.4M per year.
- Avalyn Pharmaceuticals's estimated revenue per employee is $155,000
- Avalyn Pharmaceuticals's total funding is $287M.
Employee Data
- Avalyn Pharmaceuticals has 54 Employees.
- Avalyn Pharmaceuticals grew their employee count by 35% last year.
Avalyn Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Clinical Operations | Reveal Email/Phone |
2 | SVP, Business Operations | Reveal Email/Phone |
3 | SVP | Reveal Email/Phone |
4 | SVP, Clinical Development Operations | Reveal Email/Phone |
5 | SVP, Product Development | Reveal Email/Phone |
6 | Sr VP | Reveal Email/Phone |
7 | SVP, Business Operations | Reveal Email/Phone |
8 | SVP, Clinical Development | Reveal Email/Phone |
9 | VP Medical Affairs | Reveal Email/Phone |
10 | Director, Product Development | Reveal Email/Phone |
Avalyn Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Avalyn Pharmaceuticals?
$287M
Total Funding
54
Number of Employees
$8.4M
Revenue (est)
35%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Avalyn Pharmaceuticals News
2022-04-06 - BioWorld MedTech Patent Highlights: Week 13
For prior patenting published Avalyn Pharma's former name (Genoa Pharmaceuticals) in which one of the inventors (Surber) described...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.9M | 54 | 0% | N/A |
#2 | $7.6M | 54 | -2% | N/A |
#3 | $13.1M | 54 | -17% | N/A |
#4 | $12M | 54 | 0% | N/A |
#5 | $12.2M | 54 | 15% | N/A |